Senator Rand Paul's bill, the Royalty Transparency Act of 2024, passed in the Senate Homeland Security and Governmental Affairs Committee, mandating NIH scientists to publicly disclose royalty earnings from drug companies.
Rand Paul's bill passed by the Senate Homeland Security and Governmental Affairs Committee mandates NIH scientists to disclose royalties from drug companies in their financial disclosures, available online for public view. The Royalty Transparency Act of 2024 aims to address potential conflicts of interest as scientists at the NIH have earned an estimated $400M in royalties over the past decade.
March 07, 2024
4 Articles